Log In
BCIQ
Print this Print this
 

MBX-400

  Manage Alerts
Collapse Summary General Information
Company Microbiotix Inc.
DescriptionPotent nucleoside DNA polymerase inhibitor
Molecular Target
Mechanism of ActionDNA polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCytomegalovirus (CMV)
Indication DetailsTreat cytomegalovirus (CMV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today